.FDA refuses psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Declines to Approve MDMA Therapy, Seeking Additional Research The Nyc TimesFDA Declines Ecstasy-Based Medication The Exchange JournalFDA rejects to authorize novel MDMA treatment to alleviate post-traumatic stress disorder, with ask for additional trial records CNNFDA turns down initially psychedelic to handle post-traumatic stress disorder, asking for even more research The Washington Blog post.